LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

Developing Effective Processes to Manage Risk in M&A Transactions

August 2013Mergers & AcquisitionHealthcare

Abstract

By their very nature, merger and acquisition (M&A) transactions can be unwieldy and complicated. The number of people involved and the different functional areas involved seem to grow exponentially as transaction size increases, and each person or functional area brings a different viewpoint and agenda to the table. The timeline is frequently aggressive and sometimes driven by considerations not within the control of the parties. The opportunities and risks are often sizeable and sometimes involve complicated cross-border elements. To complicate matters even further, the term “M&A” includes a wide variety of transactions, from strategic equity or debt investments or small asset purchases all the way up to multi-billion dollar, acquisitions with worldwide impact. All of these factors create inherent risk in M&A transactions, clearly at a legal level but also at a business level. This article lays out some considerations in the form of a multi-step approach, to help manage this risk.

Subscribe to reador
PLS Logo Copyright & permissions

Author

Derek Devgun

Senior Legal Specialist Mergers and Acquisitions, Medtronic Inc., USA

Related Papers

Anatomy of a Deal: Good Things Come in Small (and Very Complicated) Packages
Acorda is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda recently completed the acquisition of Biotie Therapies, a...Read more
Portrait image of Jane Wasman
Jane Wasman
President, International & General Counsel, Acorda Therapeutics, USA
Portrait image of Andrew Mayer
Andrew Mayer
Vice President, Legal, Acorda Therapeutics, USA
Between Board Neutrality and Control: Reimagining Hostile Takeover Defences in India with Lessons from Delaware and Asia-Pacific
Hostile takeovers have traditionally played only a limited role in the mergers and acquisitions landscape in India. This is attributable primarily to the ownership structure of most listed Indian companies,...Read more
Portrait image of Vikas Agarwal
Vikas Agarwal
Co-Founder, LegaLogic Consulting, India
Portrait image of Neha Deshmukh
Neha Deshmukh
Legal Advisor, LegaLogic Consulting, India
The rationality of legislators and business realities in M&A processes – the changing role of in-house lawyers – from advisors to strategic partners
The current regulatory environment in the European Union, but also in Poland, poses challenges for businesses that go beyond the traditional legal framework. Dynamic legislative changes, often introduced without public...Read more
Portrait image of Magdalena Kawczynska
Magdalena Kawczynska
Legal Director/CEE&Baltics, Ayvens, Poland
India’s M&A Landscape: Navigating Opportunities Amid Transformation
An In-depth Analysis of Key Sectors, Regulatory Frameworks, Challenges, and Emerging Trends Shaping Mergers and Acquisitions in India Indian M&A growth story: India, the world’s fifth-largest economy and one of the...Read more
Portrait image of Vani Mehta
Vani Mehta
Regional General Counsel, South Asia, General Electric Company, India
Portrait image of Pallavi Puri
Pallavi Puri
Partner, DMD Advocates, India